A Single Dose of Asenapine for the Treatment of Bipolar Patients Affected by Withdrawal Syndrome Induced Psychomotor Agitation: A Pilot, Open-Label Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.